PCT/2001/50 - World Intellectual Property Organization

50/2001
13 Dec/déc 2001 PCT Gazette - Section I - Gazette du PCT 22903
HU ID IL IN IS JP KE KG KP KR KZ LC LK LR
LS LT LU LV MA MD MG MK MN MW MX MZ
NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM
TR TT TZ UA UG UZ VN YU ZA ZW AP (GH GM
KE LS MW MZ SD SL SZ TZ UG ZW) EA (AM AZ
BY KG KZ MD RU TJ TM) EP (AT BE CH CY DE
DK ES FI FR GB GR IE IT LU MC NL PT SE TR)
OA (BF BJ CF CG CI CM GA GN GW ML MR
NE SN TD TG); (t) for the following designation
/ pour la désignation suivante : US
(u) for / pour US only / seulement
(51) 7 C07K 14/47, C12N 15/52, 15/63, C07K
16/40
(11) WO 01/94407 (13) A1
(21) PCT/CN01/00901
(22) 4 Jun/juin 2001 (04.06.2001)
(25) zh (26) zh
(30) 00 1 16373.6 7 Jun/juin 2000 CN
(07.06.2000)
(43) 13 Dec/déc 2001 (13.12.2001)
(54) • A NOVEL POLYPEPTIDE - HUMAN
UBIQUITIN-CONJUGATING ENZYME
10.01 AND A POLYNUCLEOTIDE EN-
CODING THE SAME
• NOUVEAU POLYPEPTIDE, ENZYME
DE CONJUGAISON DE L’UBIQUITINE
HUMAINE 10.01, ET POLYNUCLEO-
TIDE CODANT CE POLYPEPTIDE
(71) SHANGHAI BIOWINDOW GENE DE-
VELOPMENT INC. [CN/CN]; 12th Floor,
3rd Building, No. 1111 Zhongshan Bei Er
Road, Shanghai 200092 (CN).
(for all designated States except / pour tous
les États désignés sauf US)
(72, 75) MAO, Yumin [CN/CN]; 12th Floor, 3rd
Building, No. 1111 Zhongshan Bei Er Road,
Shanghai 200092 (CN). XIE, Yi [CN/CN];
12th Floor, 3rd Building, No. 1111 Zhongshan
Bei Er Road, Shanghai 200092 (CN).
(74) SHANGHAI HUA DONG PATENT
AGENCY; 319 Yue Yang Road, Shanghai
200031 (CN).
(81) AE AG AL AM AT AU AZ BA BB BG BR
BY BZ CA CH CO CR CU CZ DE DK DM
DZ EE ES FI GB GD GE GH GM HR HU
ID IL IN IS JP KE KG KP KR KZ LC LK
LR LS LT LU LV MA MD MG MK MN MW
MX MZ NO NZ PL PT RO RU SD SE SG SI
SK SL TJ TM TR TT TZ UA UG US UZ VN
YU ZA ZW.
Published / Publiée :(c)
Declarations / Déclarations :
(s) for the following designations / pour les
désignations suivantes : AE AG AL AM AT AU AZ
BA BB BG BR BY BZ CA CH CO CR CU CZ DE
DK DM DZ EE ES FI GB GD GE GH GM HR
HU ID IL IN IS JP KE KG KP KR KZ LC LK LR
LS LT LU LV MA MD MG MK MN MW MX MZ
NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM
TR TT TZ UA UG UZ VN YU ZA ZW AP (GH GM
KE LS MW MZ SD SL SZ TZ UG ZW) EA (AM
AZ BY KG KZ MD RU TJ TM) EP (AT BE CH CY
DE DK ES FI FR GB GR IE IT LU MC NL PT SE
TR) OA (BF BJ CF CG CI CM GA GN GW ML
MR NE SN TD TG)
(t) for the following designations / pour les
désignations suivantes : AE AG AL AM AT AU AZ
BA BB BG BR BY BZ CA CH CO CR CU CZ DE
DK DM DZ EE ES FI GB GD GE GH GM HR
HU ID IL IN IS JP KE KG KP KR KZ LC LK LR
LS LT LU LV MA MD MG MK MN MW MX MZ
NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM
TR TT TZ UA UG UZ VN YU ZA ZW AP (GH GM
KE LS MW MZ SD SL SZ TZ UG ZW) EA (AM AZ
BY KG KZ MD RU TJ TM) EP (AT BE CH CY DE
DK ES FI FR GB GR IE IT LU MC NL PT SE TR)
OA (BF BJ CF CG CI CM GA GN GW ML MR
NE SN TD TG); (t) for the following designation
/ pour la désignation suivante : US
(u) for / pour US only / seulement
(51) 7 C07K 14/47, A61K 38/17, G01N 33/50,
C12N 15/12, 15/85, C12Q 1/68
(11) WO 01/94408 (13) A1
(21) PCT/IB01/01165
(22) 6 Jun/juin 2001 (06.06.2001)
(25) en (26) en
(30) 0013807.3 6 Jun/juin 2000 GB
(06.06.2000)
(43) 13 Dec/déc 2001 (13.12.2001)
(54) • TYROSINE KINASE MODULATORS
• MODULATEURS DE TYROSINE KI-
NASE
(71) EUROPEAN MOLECULAR BIOLOGY
LABORATORY [DE/DE]; Postfach 102209,
69012 Heidelberg (DE).
(for all designated States except / pour tous
les États désignés sauf US)
(72, 75) SUPERTI-FURGA, Giulio [IT/DE];
Muhldamm 7, 69118 Heidelberg-Ziegelhausen
(DE). MORO, Marina [IT/SE];
Stenhagsvagen 90, S-752 60 Uppsala (SE).
BARILA, Daniela [IT/IT]; Via Caterina
Troiani, 276, Comp. Z49, scala A, int. 21,
I-00144 Roma (IT). PLUK, Wilhelmina
[NL/NL]; Walstro 59, NL-5432 DR Cuijk
(NL).
(74) HALLYBONE, Huw, George et al. / etc.;
Carpmaels & Ransford, 43 Bloomsbury
Square, London WC1A 2RA (GB).
(81) AE AG AL AM AT AU AZ BA BB BG BR
BY BZ CA CH CN CO CR CU CZ DE DK
DM DZ EC EE ES FI GB GD GE GH GM
HR HU ID IL IN IS JP KE KG KP KR KZ
LC LK LR LS LT LU LV MA MD MG MK
MN MW MX MZ NO NZ PL PT RO RU SD
SE SG SI SK SL TJ TM TR TT TZ UA UG
US UZ VN YU ZA ZW.
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ
UG ZW); EA (AM AZ BY KG KZ MD RU
TJ TM); EP (AT BE CH CY DE DK ES FI
FR GB GR IE IT LU MC NL PT SE TR); OA
(BF BJ CF CG CI CM GA GN GW ML MR
NE SN TD TG).
Published / Publiée :(c)
(51) 7 C07K 14/47
(11) WO 01/94409
(21) PCT/US01/18003
(13) A2
(22) 31 May/mai 2001 (31.05.2001)
(25) en (26) en
(30) 60/210,329 7 Jun/juin 2000
(07.06.2000)
US
(30) 60/248,980 14 Nov/nov 2000
(14.11.2000)
US
(30) 60/291,197 15 May/mai 2001
(15.05.2001)
US
(43) 13 Dec/déc 2001 (13.12.2001)
(54) • COMPOSITIONS AND METHODS FOR
THE THERAPY AND DIAGNOSIS OF
PANCREATIC CANCER
• TRAITEMENT ET DIAGNOSTIC DU
CANCER DU PANCREAS ET COMPO-
SITIONS A CET EFFET
(71) CORIXA CORPORATION [US/US];
1124 Columbia Street, Suite 200, Seattle, WA
98104 (US).
(for all designated States except / pour tous
les États désignés sauf US)
(72, 75) HIRST, Shannon, K. [US/US]; 801
Kirkland Way, Apt. A., Kirkland, WA 98033
(US). HARLOCKER, Susan, L. [US/US];
7522 13th Avenue W., Seattle, WA 98117
(US). DILLON, Davin, C. [US/US]; 18112
N.W. Montreux Drive, Issaquah, WA 98027
(US). KALOS, Michael, D. [US/US]; 8116
Dayton Avenue N., Seattle, WA 98103 (US).
(74) POTTER, Jane, E., R. et al. / etc.; Seed
Intellectual Property Law Group PLLC, Suite
6300, 701 Fifth Avenue, Seattle, WA 98104-
7092 (US).
(81) AE AG AL AM AT AU AZ BA BB BG BR
BY BZ CA CH CN CO CR CU CZ DE DK
DM DZ EC EE ES FI GB GD GE GH GM
HR HU ID IL IN IS JP KE KG KP KR KZ
LC LK LR LS LT LU LV MA MD MG MK
MN MW MX MZ NO NZ PL PT RO RU SD
SE SG SI SK SL TJ TM TR TT TZ UA UG
US UZ VN YU ZA ZW.
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ
UG ZW); EA (AM AZ BY KG KZ MD RU
TJ TM); EP (AT BE CH CY DE DK ES FI
FR GB GR IE IT LU MC NL PT SE TR); OA
(BF BJ CF CG CI CM GA GN GW ML MR
NE SN TD TG).
(51) 7 C07K 14/62, 14/47, A61P 3/10, A61K
31/44, G01N 33/74
(11) WO 01/94410 (13) A1
(21) PCT/SE01/01308
(22) 8 Jun/juin 2001 (08.06.2001)
(25) en (26) en
(30) 60/210,207 8 Jun/juin 2000 US
(08.06.2000)
(30) 0002189-9 9 Jun/juin 2000 SE
(09.06.2000)
(43) 13 Dec/déc 2001 (13.12.2001)
(54) • INSULIN REGULATED SUBSTANCE
(IRS-2) INDUCED BY PIOGLITAZONE,
ASSAY AND USE THEREOF
• SUBSTANCE REGULEE PAR L’IN-
SULINE (IRS-2) INDUITE PAR LA
PIOGLITAZONE, DOSAGE ET UTILI-
SATION DE CETTE DERNIERE
(71) METCON MEDICIN AB [SE/SE];
Dalénum, Hus 102B, S-181 70 Lidingö
(SE).
(for all designated States except / pour tous
les États désignés sauf US)
(72, 75) SMITH, Ulf [SE/SE]; Strandrågsvägen
8, S-434 94 Vallda (SE).
(74) HOLMBERG, Martin et al. / etc.; Bergenstråhle
& Lindvall AB, P.O. Box 17704, S-118
93 Stockholm (SE).
(81) AE AG AL AM AT AU AZ BA BB BG BR
BY BZ CA CH CN CO CR CU CZ DE DK
DM DZ EC EE ES FI GB GD GE GH GM
HR HU ID IL IN IS JP KE KG KP KR KZ
LC LK LR LS LT LU LV MA MD MG MK
MN MW MX MZ NO NZ PL PT RO RU SD